Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
881 Views
Tesla: S&P500 Inclusion (Finally) Secured
Tesla has been included in the S&P500 after 5 consecutive quarters of profitability. The passive buying on Tesla will be around US$54bn and the...
392 Views
Legend Biotech (传奇生物) IPO Trading: +27% Upside from Pricing
Legend Biotech, a leading CAR-T player, priced at USD 23/ADS and raised USD 423 million. The stock will start trading today. In this note, we will...
399 Views
Legend Biotech IPO: Pass on Valuation
Legend Biotech (LEGN US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
414 Views
Legend Biotech (传奇生物) Pre-IPO: A Good Deal for the Promising CAR-T
Legend Biotech, a subsidiary of Hong Kong-listed GenScript, started book building to raise up to USD 368 million via an IPO. The company has a...
360 Views